Idaho's state health plan and GLP-1s

What changed, and what the document says

1. The date coverage stopped

   Not covered

   One sentence, one date, and no carve-out for members already partway through a course.

   “Effective November 1, 2025, coverage for all medications prescribed for weight loss will be discontinued.”

   State of Idaho – Office of Group Insurance — September 4, 2025

2. What survived the cut

   Conditions apply

   The line is drawn at the indication, not the drug, so the same molecule can still be paid for under a different diagnosis.

   “This change does not impact coverage for GLP-1 medications when prescribed for the treatment of diabetes.”

   State of Idaho – Office of Group Insurance — September 4, 2025

3. How wide the wording goes

   Not covered

   The list of affected drugs ends with a catch-all that closes the off-label route as well as the labeled one.

   “Any GLP-1 medication prescribed primarily for weight loss, regardless of FDA approval or off-label use”

   State of Idaho – Office of Group Insurance — September 4, 2025

4. The number the office put on it

   Context

   Very few benefit notices quantify their own saving. This one answers the question in a frequently-asked-questions block.

   “Yes, the increase will be reduced by approximately $30–50 million annually, resulting in savings for both the employer and employee shares.”

   State of Idaho – Office of Group Insurance — September 4, 2025

5. Who it reaches

   Context

   Asked directly whether school districts were included, the office answered in three words.

   “Yes, it impacts all members.”

   State of Idaho – Office of Group Insurance — September 4, 2025

6. Where the memorandum sends you instead

   Context

   It recommends going direct to the manufacturers and then, to its credit, says what that means for the bill.

   “However, the member is still responsible for the full cost of the medication.”

   State of Idaho – Office of Group Insurance — September 4, 2025

7. The drug list still prints all three

   Conditions apply

   Months after the cut, the plan's published six-tier list still carries Wegovy, Zepbound and Saxenda, each marked with the indicator the same list defines below. The list alone will not tell you the answer; the memorandum will.

   “Drugs with a “+” indicator next to them on the Drug List have group-specific coverage.”

   Regence BlueShield of Idaho, published by the State of Idaho Office of Group Insurance — Six Tier Drug List Standard March 2026

Which of these companies serve Idaho?

Of the 387 companies we grade, 34 publish a list of the states they are licensed in. We checked 251 more and found no such list on any page we read; 102 we have not checked either way.

21 of those lists name Idaho: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon, Peak Wellness, Sprout Health, Allara Health, MEDvidi, and Mixx Health & Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.